423 related articles for article (PubMed ID: 24434146)
1. Suppression of protein kinase C-ζ attenuates vascular leakage via prevention of tight junction protein decrease in diabetic retinopathy.
Song HB; Jun HO; Kim JH; Yu YS; Kim KW; Kim JH
Biochem Biophys Res Commun; 2014 Jan; 444(1):63-8. PubMed ID: 24434146
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Min BH; Kim KW
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1659-65. PubMed ID: 19875648
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of genes related to blood-retina barrier disruption in streptozotocin-induced diabetes.
Klaassen I; Hughes JM; Vogels IM; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
Exp Eye Res; 2009 Jun; 89(1):4-15. PubMed ID: 19284967
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C delta attenuates blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Jun HO; Yu YS; Kim KW
Am J Pathol; 2010 Mar; 176(3):1517-24. PubMed ID: 20110406
[TBL] [Abstract][Full Text] [Related]
5. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability.
Harhaj NS; Felinski EA; Wolpert EB; Sundstrom JM; Gardner TW; Antonetti DA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5106-15. PubMed ID: 17065532
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
[TBL] [Abstract][Full Text] [Related]
7. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy.
Kim JH; Kim JH; Yu YS; Cho CS; Kim KW
J Cereb Blood Flow Metab; 2009 Mar; 29(3):621-8. PubMed ID: 19107135
[TBL] [Abstract][Full Text] [Related]
8. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
9. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
Rota R; Chiavaroli C; Garay RP; Hannaert P
Eur J Pharmacol; 2004 Jul; 495(2-3):217-24. PubMed ID: 15249173
[TBL] [Abstract][Full Text] [Related]
10. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
Li L; Renier G
Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
[TBL] [Abstract][Full Text] [Related]
11. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
12. Sac-0601 prevents retinal vascular leakage in a mouse model of diabetic retinopathy.
Maharjan S; Lee S; Agrawal V; Choi HJ; Maeng YS; Kim K; Kim NJ; Suh YG; Kwon YG
Eur J Pharmacol; 2011 Apr; 657(1-3):35-40. PubMed ID: 21296064
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of the Src inhibitor, dasatinib, on breakdown of the blood-retinal barrier.
Kim SR; Suh W
Arch Pharm Res; 2017 Feb; 40(2):197-203. PubMed ID: 27988882
[TBL] [Abstract][Full Text] [Related]
14. [Role of advanced glycation end products and activation of PKC in diabetic retinopathy].
Kaji Y; Oshika T
Nihon Rinsho; 2005 Jun; 63 Suppl 6():188-93. PubMed ID: 15999705
[No Abstract] [Full Text] [Related]
15. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
16. Stem cell factor is a potent endothelial permeability factor.
Kim JY; Choi JS; Song SH; Im JE; Kim JM; Kim K; Kwon S; Shin HK; Joo CK; Lee BH; Suh W
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1459-67. PubMed ID: 24790137
[TBL] [Abstract][Full Text] [Related]
17. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
18. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.
Canning P; Glenn JV; Hsu DK; Liu FT; Gardiner TA; Stitt AW
Exp Diabetes Res; 2007; 2007():51837. PubMed ID: 17641742
[TBL] [Abstract][Full Text] [Related]
20. ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.
Kady NM; Liu X; Lydic TA; Syed MH; Navitskaya S; Wang Q; Hammer SS; O'Reilly S; Huang C; Seregin SS; Amalfitano A; Chiodo VA; Boye SL; Hauswirth WW; Antonetti DA; Busik JV
Diabetes; 2018 Apr; 67(4):769-781. PubMed ID: 29362226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]